Healthcare providers have been calling on the government to guarantee that the value of each National Health Insurance (NHI) point is at least NT$1 to save the nation’s healthcare system, so lawmakers have proposed bills to ensure one point is worth at least NT$0.95 or NT$1. However, this would increase the NHI budget by between NT$70.5 billion and NT$115.5 billion (US$2.19 billion and US$3.59 billion) per year, which could harm its global budget payment system.
There seems to be a consensus that the guaranteed NHI point value must be increased. However, how it should be budgeted for and what supplementary measures are needed is still up for discussion.
The NHI’s payment system is an “expenditure cap” system with “floating” point values, used to precisely match the predetermined annual budget, as the total expenditure claimed by healthcare facilities for their medical services is reimbursed based on an adjusted amount multiplied by the point value.
During the COVID-19 pandemic, medical services for COVID-19-related conditions were covered by a special relief fund, but as the disease was downgraded last year, payment for medical services reverted to the NHI system. However, the increase in service volume diluted point values to nearly NT$0.7.
Facing protests by healthcare providers, the Cabinet in November last year approved an additional budget of NT$5.13 billion to make up for deficits last year, supplementing the point value and raising it to NT$0.9, and promising that it would remain at least NT$0.9 this year.
However, eight healthcare providers’ associations earlier this month issued a joint statement, urging the government to change the NHI’s global budget payment system to a “expenditure target” system, meaning that when the point value is less than NT$1, the government should make up the deficit.
Chinese Nationalist Party (KMT) legislators proposed two amendments to the National Health Insurance Act (全民健康保險法), which would ensure that one NHI point would equal at least NT$0.95 or NT$1.
The bills were first reviewed in a legislature committee on May 2, but no consensus was reached. The first cross-party negotiation was held on Wednesday last week, in which the government was asked to propose solutions within a month.
However, with global inflation, soaring commodity and housing prices, a low birthrate and a shrinking working-age population, raising the NHI premium is an issue that the government tries to avoid. More funding adds an extra burden on taxpayers and crowds out funding for other essential services.
National Health Insurance Administration Director-General Shih Chung-liang (石崇良) on Wednesday last week said the agency is considering adjusting the supplementary NHI rates to be equal to the standard premium rate, but further discussions would be needed.
Some consumer groups have said that a fixed NHI point value would undermine the NHI’s global budget payment system, incentivizing hospitals to pursue service quantity over quality.
Some experts proposed reducing the NHI budget in areas such as new technology and drugs, and preventive screening tests, which they believe should be covered by specialized government budgets, while some pharmacists also called for prescription drugs to be removed from NHI coverage.
The government, healthcare providers and civic groups all agree that there is a pressing need for NHI reform, but whether a guaranteed NHI point value should be adopted, partially adopted or other measures should be introduced is a big decision for the new Cabinet.
In their recent op-ed “Trump Should Rein In Taiwan” in Foreign Policy magazine, Christopher Chivvis and Stephen Wertheim argued that the US should pressure President William Lai (賴清德) to “tone it down” to de-escalate tensions in the Taiwan Strait — as if Taiwan’s words are more of a threat to peace than Beijing’s actions. It is an old argument dressed up in new concern: that Washington must rein in Taipei to avoid war. However, this narrative gets it backward. Taiwan is not the problem; China is. Calls for a so-called “grand bargain” with Beijing — where the US pressures Taiwan into concessions
The term “assassin’s mace” originates from Chinese folklore, describing a concealed weapon used by a weaker hero to defeat a stronger adversary with an unexpected strike. In more general military parlance, the concept refers to an asymmetric capability that targets a critical vulnerability of an adversary. China has found its modern equivalent of the assassin’s mace with its high-altitude electromagnetic pulse (HEMP) weapons, which are nuclear warheads detonated at a high altitude, emitting intense electromagnetic radiation capable of disabling and destroying electronics. An assassin’s mace weapon possesses two essential characteristics: strategic surprise and the ability to neutralize a core dependency.
Chinese President and Chinese Communist Party (CCP) Chairman Xi Jinping (習近平) said in a politburo speech late last month that his party must protect the “bottom line” to prevent systemic threats. The tone of his address was grave, revealing deep anxieties about China’s current state of affairs. Essentially, what he worries most about is systemic threats to China’s normal development as a country. The US-China trade war has turned white hot: China’s export orders have plummeted, Chinese firms and enterprises are shutting up shop, and local debt risks are mounting daily, causing China’s economy to flag externally and hemorrhage internally. China’s
US President Donald Trump and Chinese President Xi Jinping (習近平) were born under the sign of Gemini. Geminis are known for their intelligence, creativity, adaptability and flexibility. It is unlikely, then, that the trade conflict between the US and China would escalate into a catastrophic collision. It is more probable that both sides would seek a way to de-escalate, paving the way for a Trump-Xi summit that allows the global economy some breathing room. Practically speaking, China and the US have vulnerabilities, and a prolonged trade war would be damaging for both. In the US, the electoral system means that public opinion